相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Checkpoint Inhibitor-Associated Arthritis A Systematic Review of Case Reports and Case Series
Nilasha Ghosh et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis
Yuli Guzman-Prado et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related Cholangiohepatitis
Laura Moi et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors
Inbar Finkel et al.
JOURNAL OF IMMUNOTHERAPY (2020)
Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer
Karthik Suresh et al.
CLINICAL LUNG CANCER (2020)
Morphological spectrum of immune check-point inhibitor therapy-associated gastritis
Melanie Johncilla et al.
HISTOPATHOLOGY (2020)
Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade
Jessica Galant-Swafford et al.
ONCOLOGY (2020)
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Divyanshu Dubey et al.
ANNALS OF NEUROLOGY (2020)
TATTON: a multi-arm, phase lb trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
G. R. Oxnard et al.
ANNALS OF ONCOLOGY (2020)
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study
Frank B. Cortazar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition
Amanda D. Bucheit et al.
MELANOMA RESEARCH (2020)
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review
Claire Rempenault et al.
ARTHRITIS CARE & RESEARCH (2020)
It Is Time to Talk About Fertility and Immunotherapy
Narjust Duma et al.
ONCOLOGIST (2020)
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
Takumi Onoyama et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect
J. Boegeholz et al.
BMC CANCER (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis
R. Kurokawa et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2020)
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis
Lili Zhang et al.
CIRCULATION (2020)
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
Yi-Te Huang et al.
FRONTIERS IN NEUROLOGY (2020)
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Omar Mamlouk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Chronic immune checkpoint inhibitor pneumonitis
Jarushka Naidoo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Immune checkpoint inhibitor-associated celiac disease
Yousef Badran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Thomas Yau et al.
JAMA ONCOLOGY (2020)
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
Jamie S. Lin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Bairavi Shankar et al.
JAMA ONCOLOGY (2020)
Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
Jennifer Cautela et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
PRELIMINARY REVIEW OF DIABETES MELLITUS INCIDENCE IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI) THERAPY - ROSWELL PARK COMPREHENSIVE CANCER CENTER (RPCCC) EXPERIENCE
Zhen Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature
Lisa M. Cordes et al.
CLINICAL CASE REPORTS (2020)
Arthritis After Cancer Immunotherapy: Symptom Duration and Treatment Response
Melanie H. Smith et al.
ARTHRITIS CARE & RESEARCH (2019)
Nivolumab-induced aplastic anemia: A case report and literature review
Rachel R. Comito et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
Chipman R. G. Stroud et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
Sandhya Manohar et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
Immune checkpoint inhibitor therapy-induced hypophysitis ∼ a case series of Taiwanese patients
Chia-Hung Lin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition
Vylyny Chat et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer
Khinh Ranh Voong et al.
CLINICAL LUNG CANCER (2019)
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
Pauline De Bruyn et al.
CURRENT OPINION IN ONCOLOGY (2019)
A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors
Jeroen de Filette et al.
HORMONE AND METABOLIC RESEARCH (2019)
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
Celeste Lebbe et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients
Maxim Polansky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
Neal Ready et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Karthik Suresh et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
Vicky Makker et al.
LANCET ONCOLOGY (2019)
Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester: case report and review of the literature
Wen Xu et al.
MELANOMA RESEARCH (2019)
Hematologic Complications of Immune Checkpoint Inhibitors
Elizabeth J. Davis et al.
ONCOLOGIST (2019)
Late-onset Stevens-Johnson syndrome due to nivolumab use for hepatocellular carcinoma
Constantin A. Dasanu
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Hao Chi Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Paul La Rosee et al.
BLOOD (2019)
Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy
Xi Chen et al.
CLINICAL NEUROPHYSIOLOGY (2019)
Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis
Elisa Guerrero et al.
EUROPEAN JOURNAL OF CANCER (2019)
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain The Alliance A221304 Randomized Clinical Trial
Terence T. Sio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy
Blake M. Warner et al.
ONCOLOGIST (2019)
Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors
Tenglong Tang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials A Systematic Review and Meta-analysis
Yucai Wang et al.
JAMA ONCOLOGY (2019)
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Douglas B. Johnson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Jonathan D. Schoenfeld et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Kidney Complications of Immune Checkpoint Inhibitors: A Review
Roman Shingarev et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
Jeroen M. K. de Filette et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma
Erika F. Rodriguez et al.
HUMAN PATHOLOGY (2019)
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas
Pooja H. Rambhia et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Hamzah Abu-Sbeih et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Gregory S. Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
Khashayar Esfahani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis
Joe-Elie Salem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
Julia Lai-Kwon et al.
JOURNAL OF CANCER SURVIVORSHIP (2019)
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
Audrey Simonaggio et al.
JAMA ONCOLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E. W. Cohen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: updates diagnostic hazard of autoimmunity at a distance
Marcus A. Couey et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis An Official American Thoracic Society Research Statement
Catherine R. Sears et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial
S. R. Rathinam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Karthik Suresh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
Divyanshu Dubey et al.
NEUROLOGY (2019)
Early infliximab in life-threatening immune-mediated pneumonitis
T. Cooksley et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)
An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals
Michael C. Sneller et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The importance of early identification of infusion-related reactions to monoclonal antibodies
Macarena C. Caceres et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
Alberto Vogrig et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
1775PIncidence of vascular thromboembolism events in cancer patients receiving immunotherapy: A single institution experience
L Gutiérrez Sainz et al.
ANNALS OF ONCOLOGY (2019)
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Harish Seethapathy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
Alessio Cortellini et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
Houssein Safa et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms
Julienne E. Bower
CANCER (2019)
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
Alvaro Moreira et al.
EUROPEAN JOURNAL OF CANCER (2019)
Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review
Georges E. Tanios et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
Patrick Arnaud-Coffin et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab
Chanakyaram A. Reddy et al.
IMMUNOTHERAPY (2019)
The IASP classification of chronic pain for ICD-11: chronic cancer-related pain
Michael Bennett et al.
PAIN (2019)
Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis
Laura C. Cappelli et al.
RHEUMATOLOGY (2019)
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria A Meta-analysis of Real-world Evidence
Michael D. Tharp et al.
JAMA DERMATOLOGY (2019)
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Shazli Azmi et al.
DIABETES THERAPY (2019)
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Omar Mamlouk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Ulrich Keilholz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
Guillaume Manson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunotherapy-induced acute pulmonary thromboembolism: A case report
Waseem Abbas et al.
SOUTH ASIAN JOURNAL OF CANCER (2019)
Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis
Changhee Park et al.
ESMO OPEN (2019)
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer
Yu Nakanishi et al.
RESPIRATORY INVESTIGATION (2019)
Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
Cassandra Calabrese et al.
RMD OPEN (2019)
Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis
Roberto Alfaro-Lara et al.
REUMATOLOGIA CLINICA (2019)
Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature
Alessandro Brancatella et al.
EUROPEAN THYROID JOURNAL (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Rational management approach to pure red cell aplasia
Suresh Kumar Balasubramanian et al.
HAEMATOLOGICA (2018)
Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report
Shigeki Numata et al.
JOURNAL OF DERMATOLOGY (2018)
Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab
Yutaka Kuwatsuka et al.
JOURNAL OF DERMATOLOGY (2018)
Effects of acupuncture on cancer-related fatigue: a meta-analysis
Yan Zhang et al.
SUPPORTIVE CARE IN CANCER (2018)
Rational management approach to pure red cell aplasia
Suresh Kumar Balasubramanian et al.
HAEMATOLOGICA (2018)
The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors
Heinz Laubli et al.
ONCOIMMUNOLOGY (2018)
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease A Systematic Review
Noha Abdel-Wahab et al.
ANNALS OF INTERNAL MEDICINE (2018)
Safety Profile of Avelumab in Patients With Advanced Solid Tumors: A Pooled Analysis of Data From the Phase 1 JAVELIN Solid Tumor and Phase 2 JAVELIN Merkel 200 Clinical Trials
Karen Kelly et al.
CANCER (2018)
Vasculitis associated with immune checkpoint inhibitors-a systematic review
Anisha Daxini et al.
CLINICAL RHEUMATOLOGY (2018)
Long-Term Effects of Lifestyle Intervention and Metformin during DPP on Appendicular Lean Mass
Ann V. Schwartz et al.
DIABETES (2018)
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
Francois-Xavier Danlos et al.
EUROPEAN JOURNAL OF CANCER (2018)
Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis
Eric Gars et al.
HAEMATOLOGICA (2018)
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis
Yinghong Wang et al.
INFLAMMATORY BOWEL DISEASES (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Fa-Ping Wang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy
Jacob Siegel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity
John A. Thompson
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
Sara Valpione et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone et al.
LANCET ONCOLOGY (2018)
Pembrolizumab-induced acute thrombosis: A case report
Kei Kunimasa et al.
MEDICINE (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis
Sunita M. C. De Sousa et al.
PITUITARY (2018)
CHECKPOINT INHIBITOR IMMUNE THERAPY Systemic Indications and Ophthalmic Side Effects
Lauren A. Dalvin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Viable Pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy
Mauricio Burotto et al.
SEMINARS IN ONCOLOGY (2018)
Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab
Kanako Sakurai et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis
Eric Gars et al.
HAEMATOLOGICA (2018)
Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC
Fernando C. Santini et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
Chun-Bing Chen et al.
CANCER MANAGEMENT AND RESEARCH (2018)
EGFR-TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non-Small Cell Lung Cancer
Yasuo Oshima et al.
JAMA ONCOLOGY (2018)
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J. Sullivan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab
Fanny Zulay Acero Brand et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Yinghong Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
Julie R. Brahmer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors
Karthik Suresh et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials
Muhammad Khan et al.
MEDICINE (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
Priyanka C. Iyer et al.
THYROID (2018)
Immune Checkpoint Inhibitor-Associated Colits and Hepatitis
Haritha G. Reddy et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Daniel Y. Wang et al.
JAMA ONCOLOGY (2018)
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
Guacimara Ortega Sanchez et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Checkpoint inhibitors: What gastroenterologists need to know
Monjur Ahmed
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
Nicolas Delanoy et al.
Lancet Haematology (2018)
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Norbaini Binti Abdol Razak et al.
CANCERS (2018)
Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2018)
CYCLOPHOSPHAMIDE FOR THE TREATMENT OF REFRACTORY CHRONIC HYPERSENSITIVITY PNEUMONITIS
R. A. Hastings et al.
THORAX (2018)
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
Devis Benfaremo et al.
CURRENT DRUG SAFETY (2018)
Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma
Trevor E. Angell et al.
GENES & DISEASES (2018)
Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases
Jessica Tsukamoto et al.
CASE REPORTS IN ONCOLOGY (2018)
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies
Kristina Buder-Bakhaya et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Cyclophosphamide for connective tissue disease-associated interstitial lung disease
Hayley Barnes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Stevens-Johnson syndrome during nivolumab treatment of NSCLC
M. Salati et al.
ANNALS OF ONCOLOGY (2018)
Cancer immunotherapy-associated hypophysitis
Cinzia Solinas et al.
SEMINARS IN ONCOLOGY (2018)
Dermatologic Reactions to Immune Checkpoint Inhibitors Skin Toxicities and Immunotherapy
Vincent Sibaud
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature
L. Spain et al.
ANNALS OF ONCOLOGY (2017)
Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury
F. Gelsomino et al.
ANNALS OF ONCOLOGY (2017)
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
J. C. Osorio et al.
ANNALS OF ONCOLOGY (2017)
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A. M. Menzies et al.
ANNALS OF ONCOLOGY (2017)
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Laura C. Cappelli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab
Ryota Tanaka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab plus Ipilimumab
Claire F. Friedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab plus Ipilimumab
Claire F. Friedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Endocrine side effects of cancer immunotherapy
Priscilla Cukier et al.
ENDOCRINE-RELATED CANCER (2017)
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
Ralf Gutzmer et al.
EUROPEAN JOURNAL OF CANCER (2017)
Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies
Alice Bernard-Tessier et al.
EUROPEAN JOURNAL OF CANCER (2017)
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
S. Cuzzubbo et al.
EUROPEAN JOURNAL OF CANCER (2017)
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis
Sebastien Le Burel et al.
EUROPEAN JOURNAL OF CANCER (2017)
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
Omar Abdel-Rahman et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
Hisato Kawakami et al.
INVESTIGATIONAL NEW DRUGS (2017)
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities
Clelia Coutzac et al.
JOURNAL OF CROHNS & COLITIS (2017)
Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy
Karina L. Vivar et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
Kendrick Co Shih et al.
JOURNAL OF INFLAMMATION-LONDON (2017)
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis
Julia Dai et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer
Sriram Yennurajalingam et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report
Takeshi Uenami et al.
LUNG CANCER (2017)
Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature
Juan Ruiz-Banobre et al.
LUNG CANCER (2017)
Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review
Mei Fang Zeng et al.
MEDICINE (2017)
Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination
Jeremy Lupu et al.
MELANOMA RESEARCH (2017)
A Case Report of Drug-Induced Myopathy Involving Extraocular Muscles after Combination Therapy with Tremelimumab and Durvalumab for Non-Small Cell Lung Cancer
William Carrera et al.
NEURO-OPHTHALMOLOGY (2017)
Inflammatory Orbitopathy Associated With Ipilimumab
Claire A. Sheldon et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2017)
Acupuncture for cancer-related fatigue in lung cancer patients: a randomized, double blind, placebo-controlled pilot trial
Chien-shan Cheng et al.
SUPPORTIVE CARE IN CANCER (2017)
Autoimmune hepatitis: standard treatment and systematic review of alternative treatments
Benedetta Terziroli Beretta-Piccoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
Laura C. Cappelli et al.
ARTHRITIS CARE & RESEARCH (2017)
Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature
Hiroshi Takeyama et al.
ONCOLOGY LETTERS (2017)
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
Marlene Garcia-Neuer et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysis
Daniel Y. Wang et al.
ONCOIMMUNOLOGY (2017)
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue A Meta-analysis
Karen M. Mustian et al.
JAMA ONCOLOGY (2017)
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Ashish M. Kamat et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
Eileen Shiuan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Nivolumab, a new immunomodulatory drug, a new adverse effect; adrenal crisis
Funda Karbek Akarca et al.
TURKISH JOURNAL OF EMERGENCY MEDICINE (2017)
Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
Gary Joseph Doherty et al.
ESMO OPEN (2017)
Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors
Dimitri Arangalage et al.
ANNALS OF INTERNAL MEDICINE (2017)
Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
B. El Osta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice et al.
CLINICAL THERAPEUTICS (2017)
Severe Esophagitis and Gastritis from Nivolumab Therapy
Justin Boike et al.
ACG CASE REPORTS JOURNAL (2017)
Tubulointerstitial Nephritis as the Initial Presentation of Crohn's Disease and Successful Treatment with Infliximab
Brielle Stanton et al.
ACG CASE REPORTS JOURNAL (2017)
Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism
Myint Aung Win et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
Monica Khunger et al.
CHEST (2017)
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma
H. Helgadottir et al.
ANNALS OF ONCOLOGY (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study
Emi Dika et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2017)
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis
Julie Morisset et al.
CHEST (2017)
Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features
Michael T. Tetzlaff et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2017)
Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights
Alexander Faje
PITUITARY (2016)
Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia
Johanna Kulpa et al.
WIENER KLINISCHE WOCHENSCHRIFT (2016)
Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients
Anushree C. Shirali et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report
Alfred Basilious et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2016)
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
Mizuki Nishino et al.
CLINICAL CANCER RESEARCH (2016)
Cyclosporine for Dry Eye Associated With Nivolumab: A Case Progressing to Corneal Perforation
Alexander T. Nguyen et al.
CORNEA (2016)
A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Magic Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304)
R. C. Miller et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
Zuo-Tao Zhao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
Stefan R. Bornstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease
L. Marthey et al.
JOURNAL OF CROHNS & COLITIS (2016)
Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?
Stefan Diem et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma
Namrata Nayar et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort
Shelley Ji Eun Hwang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Clinical practice guidelines for oral management of Sjogren disease Dental caries prevention
Domenick T. Zero et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2016)
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Frank B. Cortazar et al.
KIDNEY INTERNATIONAL (2016)
Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma - Case Series and Review
F. C. Fierz et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2016)
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
Anas Younes et al.
LANCET ONCOLOGY (2016)
EFFICACY OF PREDNISONE FOR THE TREATMENT OF OCULAR MYASTHENIA (EPITOME): A RANDOMIZED, CONTROLLED TRIAL
Michael Benatar et al.
MUSCLE & NERVE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma
Kirollos S. Hanna
PHARMACOTHERAPY (2016)
Nivolumab-associated acute glomerulonephritis: a case report and literature review
Kyungsuk Jung et al.
BMC NEPHROLOGY (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
Fulminant type1 diabetes mellitus with anti-programmed cell death-1 therapy
Masahide Okamoto et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy
Veronica J. Shi et al.
JAMA DERMATOLOGY (2016)
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
Camille Hua et al.
JAMA DERMATOLOGY (2016)
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
Jarushka Naidoo et al.
CANCER IMMUNOLOGY RESEARCH (2016)
High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis
Siraj Mithoowani et al.
LANCET HAEMATOLOGY (2016)
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino et al.
JAMA ONCOLOGY (2016)
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
Douglas B. Johnson et al.
JAMA ONCOLOGY (2016)
Acute visual loss after ipilimumab treatment for metastatic melanoma
Melissa A. Wilson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Safety and clinical activity of anti-programmed death-ligand 1 (PD-L1) antibody (ab) avelumab (MSB0010718C) in advanced thymic epithelial tumors (TETs).
Arun Rajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
In vivo Confocal Microscopy in Differentiating Ipilimumab-Induced Anterior Uveitis from Metastatic Uveal Melanoma
Hayyam Kiratli et al.
CASE REPORTS IN OPHTHALMOLOGY (2016)
Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure
Andrea L. DiCarlo et al.
JOURNAL OF RADIATION ONCOLOGY (2016)
Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
Hsiao-Han Wang et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Immune therapy in autoimmune encephalitis: a systematic review
Margherita Nosadini et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis
Mahmoud H. Mosli et al.
INFLAMMATORY BOWEL DISEASES (2015)
Treatment possibilities of ipilimumab-induced thrombocytopenia-case study and literature review
Jindrich Kopecky et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma
Douglas B. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Safety of Infusing Ipilimumab Over 30 Minutes
Parisa Momtaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
Hansje-Eva Teulings et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al.
LANCET ONCOLOGY (2015)
Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy
Erik Letko et al.
OPHTHALMOLOGY (2015)
Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab
David R. Minor et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Immune therapy in autoimmune encephalitis: a systematic review
Margherita Nosadini et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
Ahmad A. Tarhini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
Jing Hughes et al.
DIABETES CARE (2015)
Kidney injuries related to ipilimumab
Hassane Izzedine et al.
INVESTIGATIONAL NEW DRUGS (2014)
Randomized Controlled Trial of a Cognitive-Behavioral Therapy Plus Hypnosis Intervention to Control Fatigue in Patients Undergoing Radiotherapy for Breast Cancer
Guy H. Montgomery et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Modafinil for the Treatment of Fatigue in Lung Cancer: Results of a Placebo-Controlled, Double-Blind, Randomized Trial
Anna Spathis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation
Julienne E. Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Managing xerostomia and salivary gland hypofunction Executive summary of a report from the American Dental Association Council on Scientific Affairs
Jacqueline M. Plemons et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2014)
Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash
Neelima N. Nallapaneni et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
Jacqueline Jonklaas et al.
THYROID (2014)
The Effect of Yoga Exercise on Improving Depression, Anxiety, and Fatigue in Women With Breast Cancer: A Randomized Controlled Trial
Chao-Jung Taso et al.
JOURNAL OF NURSING RESEARCH (2014)
Retinal vasculitis and ocular vitreous metastasis following complete response to PD-I inhibition in a patient with metastatic cutaneous melanoma
Joshua S. Manusow et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Management of Steroid-Induced Hyperglycemia in Hospitalized Patients With Cancer: A Review
Veronica J. Brady et al.
ONCOLOGY NURSING FORUM (2014)
Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications
Julienne E. Bower et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Organizing Pneumonia as a Side Effect of Ipilimumab Treatment of Melanoma
Igor Z. Barjaktarevic et al.
CHEST (2013)
Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus
Peter A. Banks et al.
GUT (2013)
Systematic Monitoring and Treatment of Physical Symptoms to Alleviate Fatigue in Patients With Advanced Cancer: A Randomized Controlled Trial
Pleun J. de Raaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2
Debra L. Barton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
Antoni Ribas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Ipilimumab-induced autoimmune adrenalitis
Le Min et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
Arjun Muralidharan et al.
INFLAMMOPHARMACOLOGY (2013)
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
John A. Kellum et al.
CRITICAL CARE (2013)
Diagnosis and Management Of POST-Transfusion Purpura - Case Report
Fabiana Mendes Conti et al.
BLOOD (2013)
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Bhaskar Dasgupta et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A Case of Pituitary Metastasis from Breast Cancer That Presented as Left Visual Disturbance
Young Ha Kim et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2012)
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
Helena Trottestam et al.
BLOOD (2011)
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Evelyn Sarnes et al.
CLINICAL THERAPEUTICS (2011)
Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.
M. K. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effectiveness of treatment guidance on diarrhea and colitis across ipilimumab studies.
S. O'Day et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Hemophilia A Induced by Ipilimumab
Julie Delyon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods
Jessica A. Reese et al.
BLOOD (2010)
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance
Carol Moreno et al.
BLOOD (2010)
The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials
Yuan-Han Qin et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
Epidemiology and pathophysiology of cancer-associated thrombosis
S. Noble et al.
BRITISH JOURNAL OF CANCER (2010)
Placebo and Nocebo Effects in Randomized Double-Blind Clinical Trials of Agents for the Therapy for Fatigue in Patients With Advanced Cancer
Maxine de la Cruz et al.
CANCER (2010)
Low-dose rituximab in adult patients with primary immune thrombocytopenia
Francesco Zaja et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Amanda R. Moraska et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Systematic Review of the Treatment of Nausea and/or Vomiting in Cancer Unrelated to Chemotherapy or Radiation
Mellar P. Davis et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer
Miiru Izumi et al.
RESPIROLOGY (2010)
Venous thromboembolism and prognosis in cancer
Alok A. Khorana
THROMBOSIS RESEARCH (2010)
Drug therapy for the management of cancer-related fatigue
Ollie Minton et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Treatment of Polymyalgia Rheumatica A Systematic Review
Jose Hernandez-Rodriguez et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Tetrada of the possible mycophenolate mofetil embryopathy: A review
Paul Merlob et al.
REPRODUCTIVE TOXICOLOGY (2009)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer -: A systematic review and meta-analysis
Elie A. Akl et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
Alberto Alonso-Ruiz et al.
BMC MUSCULOSKELETAL DISORDERS (2008)
Autoimmune thrombocytopenia in non-Hodgkin's lymphomas
Alexander W. Hauswirth et al.
HAEMATOLOGICA (2008)
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
Elie A. Akl et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis
E. Gonzalez et al.
KIDNEY INTERNATIONAL (2008)
The Ashwell receptor mitigates the lethal coagulopathy of sepsis
Prabhjit K. Grewal et al.
NATURE MEDICINE (2008)
Cancer-related fatigue: A systematic and meta-analytic review of non-pharmacological therapies for cancer patients
Maria Kangas et al.
PSYCHOLOGICAL BULLETIN (2008)
Even low dose of mycophenolate mofetil in a mother recipient of heart transplant can seriously damage the fetus
Jose Henrique Andrade Vila et al.
TRANSPLANTATION (2008)
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease
E. J. Cepeda et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Exercise for the management of cancer-related fatigue in adults
F. Cramp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Immunotherapy for Guillain-Barre syndrome:: a systematic review
Richard A. C. Hughes et al.
BRAIN (2007)
Thiopurine-induced liver injury in patients with inflammatory bowel disease:: A systematic review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
A. Lazo-Langner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression
Dan Turner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Systematic review: infliximab therapy in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Effects of glucocorticoids on radiological progression in rheumatoid arthritis
J. R. Kirwan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Cancer-related fatigue: The scale of the problem
Maarten Hofman et al.
ONCOLOGIST (2007)
Mycophenolate mofetil for the treatment of interstitial nephritis
Dean C. Preddie et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy
J Thumfart et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Corticosteroids for myasthenia gravis - art. no. CD002828.pub2
C Scheider-Gold et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer
P Glare et al.
SUPPORTIVE CARE IN CANCER (2004)
Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone
C Fukushima et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2003)
分享论文
